Summary
Differences in action between imipramine (Tofranil®) and desipramine (Pertofran®), a metabolite of imipramine, in normal persons and in depressive patients are described. Correlations with the pharmacological findings of each comparative substance are discussed. If the comparison is limited to the therapeutic action, the two substances show rather similar properties, although there are some differences which seem to us important. On the other hand, the two comparative substances differ much more clearly in their effects in healthy subjects, where even opposite effects can be observed. Namely desipramine in the healthy subject shows a rather potent depressor effect and a slow onset of action, whereas in patients the drug has a short latent period and has a certain stimulant effect. Imipramine on the other hand acts rather slowly in patients but more quickly in healthy persons. It has scarcely any stimulant action, either in normal subjects or in depressive patients.
References
Ban, T. A., and H. E. Lehmann: Clinical trial with desmethylimipramine (G35020), a new antidepressive compound. Canad. med. Ass. J. 86, 22, 1030–1031 (1961).
Battegay, R.: Vergleichende Bewertung antidepressiv wirksamer Psychopharmaka unter besonderer Berücksichtigung von Pertofran (Desmethylimipramin) G 35020. Meeting of the Collegium Internat. Neuro-Psychopharmacologicum, Munich 1962.
Brodie, B., P. Dick, P. Kielholz, W. Pöldinger and W. Theobald: Preliminary pharmacological and clinical results with desmethylimipramine (DMI) G 35020, a metabolite of Tofranil. Psychopharmacologia (Berl.) 2, 6, 467–474 (1961).
Degkwitz, R.: Über die Tofranil-Wirkung bei langfristigen Selbstversuchen. Med. exp. (Basel) 5, 233–238 (1961).
Fevers, C., D. Huthmacher u. H. Reiling: Medizinisch-psychologische Untersuchungen über die Tofranil-Wirkung bei Gesunden und Kranken. Z. Psychother. med. Psychol. 11, 127–142 (1961).
Gillette, J. R., J. V. Dingell, F. Sulser, R. Kuntzman and B. B. Brodie: Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine (Tofranil). Experientia (Basel) 17, 417–418 (1961).
Grünthal, E.: Untersuchungen über die besondere psychologische Wirkung des Thymoleptikums Tofranil. Psychiat. et Neurol. (Basel) 136, 6, 402–408 (1962).
Herrmann, B., u. R. Pulver: Der Stoffwechsel des Psychopharmakons Tofranil. Arch. int. Pharmacodyn. 126, 454–469 (1960).
— u. R. Pulver: Papierchromatographischer Nachweis von Stoffwechselprodukten des Tofranil. Med. exp. (Basel) 1, 381–383 (1959).
Mann, A. M.: Desmethylimipramine (G 35020) in the treatment of depression: Pilot study in a general hospital and out-patient setting. Canad. med. Ass. J. 86, 11, 495–498 (1962).
Oltman, J. E., and S. Friedman: Preliminary investigation of desmethylimipramine (G 35020). Amer. J. Psychiat. 119, 4, 370–371 (1962).
Pöldinger, W.: Schweiz. Arch. Neurol. Psychiat. 84, 327 (1959).
- 136th Meeting of the Swiss Psychiatric Assoc., Bern 1962.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pöldinger, W. Comparison between imipramine and desipramine in normal subjects and their action in depressive patients. Psychopharmacologia 4, 302–307 (1963). https://doi.org/10.1007/BF00408186
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00408186